Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

An overview of current and emerging devices for percutaneous left atrial appendage closure

Research output: Contribution to journalReviewResearchpeer-review

  1. Symptoms and healthcare contact preceding sudden cardiac death in persons aged 1-49 years

    Research output: Contribution to journalReviewResearchpeer-review

  2. Editorial Commentary: When should the patient with an inherited cardiac disease have an ICD?

    Research output: Contribution to journalEditorialResearchpeer-review

  3. β-Adrenergic regulation of the cardiac Na+-K+ ATPase mediated by oxidative signaling

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Glucagon-like peptide 1--a cardiologic dimension

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Temporal trends in utilization of transcatheter aortic valve replacement and patient characteristics: a nationwide study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Incidence of Infective Endocarditis Among Patients With Tetralogy of Fallot

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Patient-Specific Implantation Technique to Obtain Neo-Commissural Alignment With Self-Expanding Transcatheter Aortic Valves

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Technical Considerations for Transcatheter Aortic Valve Replacement With the Navitor Transcatheter Heart Valve

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Danny H F Chow
  • Yam-Hong Wong
  • Jai-Wun Park
  • Yat-Yin Lam
  • Tom De Potter
  • Josep Rodés-Cabau
  • Lluis Asmarats
  • Marcus Sandri
  • Eleftherios Sideris
  • Trevor McCaw
  • Randall J Lee
  • Horst Sievert
  • Lars Søndergaard
  • Ole De Backer
View graph of relations

Atrial fibrillation (AF) is common and is a prominent risk factor for ischemic stroke. Oral anticoagulant (OAC) therapy has been the main strategy for stroke prevention in AF patients; however, OAC therapy carries a bleeding risk and is not tolerated by all patients. Left atrial appendage (LAA) closure offers a non-pharmacological alternative for stroke prevention in patients with non-valvular AF. In this update, an overview of current and emerging LAA occluders is given - with special attention to the key design features of every single device and, if available, preclinical or clinical data.

Original languageEnglish
JournalTrends in Cardiovascular Medicine
Volume29
Issue number4
Pages (from-to)228-236
Number of pages9
ISSN1050-1738
DOIs
Publication statusPublished - 2019

    Research areas

  • Animals, Atrial Appendage/physiopathology, Atrial Fibrillation/complications, Cardiac Catheterization/adverse effects, Equipment Design, Humans, Risk Factors, Stroke/diagnosis, Treatment Outcome

ID: 56524064